Sign in

or Register now

MyBreastCancerNetwork.com

    See all of our health sites at www.HealthCentral.com
    Tuesday, November, 24, 2009
    • Font size
    • Bookmark
    • Save
    Featured ContentWhat If? Statistics and Public Health

    All SharePosts Relating To "aromatase inhibitors"

    EXPERT
    Cancer Vixen

    Cancer Vixen

    (Profile)
    Fashionista - Activista - Cartoonist
    Our Expert |  Been Through It
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 03/04/2009, comments (8)

    SOY-anara!

    Over the weekend, a woman at the young survivors conference (the 9th Annual Conference for Young Women Affected by Breast Cancer) asked an oncologist from Dana Farber about soy. His response was that you'd have to eat "a ton" of it for the soy to have an effect on your cancer. Gee, thanks for the awesomely unspecific answer, doc! Here's my... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    EXPERT
    Kevin Knopf, MD

    Kevin Knopf, MD

    (Profile)
    Medical Oncologist
    Our Expert |  Health Professional
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 02/11/2009, comments (0)

    Predicting Tamoxifen's Effectiveness: Testing for CYP2D6 Gains More Steam

    Discussed in this blog two years ago, many academicians now recommend testing for CYP2D6 metabolic signature to determine if postmenopausal women should switch from tamoxifen to aromatase inhibitors. However, given that most oncologists offer aromatase inhibitors preferentially to postmenopausal women over tamoxifen the question is still... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    EXPERT
    PJ Hamel

    PJ Hamel

    (Profile)
    Author, breast cancer survivor
    Our Expert |  Been Through It
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 12/17/2008, comments (9)

    Aromatase Inhibitors: A Silent, Potentially Deadly Side Effect - Osteoporosis

    With about 10 years of data now available, it’s becoming more and more clear that an aromatase inhibitor (AI) may be the hormone-therapy drug of choice for preventing breast cancer recurrence. Arimidex, Femara, and Aromasin—the drugs so many of us take on a daily basis—are proving more and more powerful as a cancer deterrent, for... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    EXPERT
    PJ Hamel

    PJ Hamel

    (Profile)
    Author, breast cancer survivor
    Our Expert |  Been Through It
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 07/02/2008, comments (8)

    Aromatase Inhibitor FAQs: Hormone Therapy (Arimidex, Femara, and Aromasin) for Breast Cancer

    Q. I've been on tamoxifen for a couple of years, and now my doctor is switching me to an aromatase inhibitor. I understand how tamoxifen works, but this AI is a whole new thing... how does it work? A. Aromatase inhibitors (pronounced aroma-tase: just like it looks) come in three basic flavors: Femara® (letrozole), Arimidex®... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    EXPERT
    Kevin Knopf, MD

    Kevin Knopf, MD

    (Profile)
    Medical Oncologist
    Our Expert |  Health Professional
    Get Widget TooltipGet Widget
    This widget is a small module that you can place on personalized sites (like iGoogle, Facebook, or your blog) and get automatic updates from our experts!       |  RSS
    posted 04/04/2008, comments (3)

    Triple Negative Breast Cancer: Making Sense of Estrogen, Progesterone and HER2 Receptor Status

    Most oncologists now are thinking of breast cancer as at least four diseases based on endocrine features - luminal A, luminal B, Her2 positive and the so called "triple negative" - breast cancers that express neither estrogen receptors, progesterone receptors nor Her2 receptors. These latter breast cancers, or "triple negative" breast cancers... Read moreChevron
    Read all my posts  | Subscribe | Send Message
    • Font size
    • Bookmark
    • Save

    Ask a Question

    Get answers from our experts and community members.

    View all questions (3944) >
    Related Breast Cancer Topics
    Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
    Non-Profit Affiliates:
    • National Breast Cancer Coalition
    • Men Against Breast Cancer
    Featuring Content From:
    • Harvard Health Publications
    • A.D.A.M.
    • Thomson PDR
    • Ivanhoe Broadcast News

    By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyBreastCancerNetwork.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

    This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
    • TRUSTe Certified Privacy
    • Health Care Standard of Excellence
    • FREDDIE International Health and Medical Media Award Finalist